What Researchers Did
Researchers presented a case report of a 50-year-old man with arsenic trioxide-induced mandibular osteomyelitis and reviewed relevant published data.
What They Found
They found that a 50-year-old man developed mandibular osteomyelitis and lower lip paresthesia after arsenic trioxide was used during endodontic treatment. After treatment with antibiotics, hyperbaric oxygen therapy, and surgical debridement, bone healing and periodontal health were restored at a 4-year follow-up, though paresthesia persisted.
What This Means for Canadian Patients
This case highlights the severe and lasting complications, such as osteomyelitis and nerve damage, that can arise from the historical use of arsenic trioxide in dental procedures. For Canadian patients, this reinforces the importance of current, safer endodontic practices and the need for thorough follow-up if such historical exposures are suspected.
Canadian Relevance
There is no direct Canadian connection mentioned in this study.
Study Limitations
As a case report and review, this study's findings are limited in generalizability to a broader patient population.